WMSA
TEVA icon

Weiss Multi-Strategy Advisers’s Teva Pharmaceuticals TEVA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-503,476
Closed -$5.26M – 430
2023
Q4 		$5.26M Buy
503,476
+127,127
+34% +$1.19M 0.13% 212
2023
Q3 		$3.84M Buy
376,349
+42,412
+13% +$395K 0.09% 280
2023
Q2 		$2.52M Buy
333,937
+163,639
+96% +$1.33M 0.05% 434
2023
Q1 		$1.51M Sell
170,298
-238,468
-58% -$2.36M 0.04% 461
2022
Q4 		$3.73M Buy
408,766
+157,236
+63% +$1.37M 0.11% 273
2022
Q3 		$2.03M Sell
251,530
-49,525
-16% -$438K 0.05% 397
2022
Q2 		$2.26M Buy
301,055
+259,255
+620% +$2.26M 0.07% 363
2022
Q1 		$393K Buy
+41,800
New +$349K 0.01% 579
2016
Q4 		– Sell
-7,500
Closed -$345K – 513
2016
Q3 		$345K Buy
7,500
+210
+3% +$11K 0.02% 366
2016
Q2 		$366K Sell
7,290
-3,210
-31% -$171K 0.03% 346
2016
Q1 		$562K Sell
10,500
-400
-4% -$23.5K 0.02% 380
2015
Q4 		$715K Sell
10,900
-200
-2% -$12.4K 0.05% 276
2015
Q3 		$627K Sell
11,100
-68,900
-86% -$4.47M 0.03% 302
2015
Q2 		$4.73M Sell
80,000
-25,000
-24% -$1.54M 0.19% 145
2015
Q1 		$6.54M Sell
105,000
-20,000
-16% -$1.16M 0.29% 95
2014
Q4 		$7.19M Sell
125,000
-15,000
-11% -$836K 0.25% 92
2014
Q3 		$7.53M Hold
140,000
– – 0.18% 145
2014
Q2 		$7.34M Hold
140,000
– – 0.16% 154
2014
Q1 		$7.4M Buy
140,000
+5,000
+4% +$231K 0.15% 174
2013
Q4 		$5.41M Buy
135,000
+45,000
+50% +$1.77M 0.12% 226
2013
Q3 		$3.4M Buy
90,000
+20,000
+29% +$780K 0.07% 279
2013
Q2 		$2.74M Buy
+70,000
New +$2.73M 0.08% 292

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Weiss Multi-Strategy Advisers's TEVA Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Teva Pharmaceuticals (TEVA) in Q1 2024, closing a stake of 503,476 shares — an estimated $5.26M sold.

Weiss Multi-Strategy Advisers first reported a position in TEVA in Q2 2013 and held it in 22 quarters. The position peaked at $7.53M in Q3 2014. 481 funds tracked by Wall St. Rank hold TEVA as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Teva Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 503,476 Teva Pharmaceuticals shares in Q1 2024, an estimated $5.26M.
  • Weiss Multi-Strategy Advisers first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 22 quarters.
  • Weiss Multi-Strategy Advisers's Teva Pharmaceuticals position peaked at $7.53M in Q3 2014.
  • 481 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.